Sign in

CIK 0001818382

  • Non-accelerated filer
  • Smaller reporting company

Humacyte, Inc.

Sign in to watch
Ticker
HUMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851763759
Phone
+1 919-313-9633
Business address
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
Former names
Alpha Healthcare Acquisition Corp.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale President, CEO and Director sold 630,148 shares at an average $7.17 ($4,520,024)
  9. 4 Open-market sale Director sold 630,148 shares at an average $7.17 ($4,520,024)
  10. 4 Open-market buy President, CEO and Director bought 2,362 shares at $6.35 ($14,999)
  11. 4 Open-market buy Director bought 2,362 shares at $6.35 ($14,999)
  12. 4 Open-market sale President, CEO and Director sold 1,001,852 shares at an average $7.82 ($7,832,200)
  13. 4 Open-market sale Director sold 1,001,852 shares at an average $7.82 ($7,832,200)
  14. 4 Open-market buy President, CEO and Director bought 2,050 shares at $7.37 ($15,109)
  15. 4 Open-market buy Director bought 2,050 shares at $7.37 ($15,109)
  16. 4 Open-market sale Chief Operating Officer sold 191,511 shares at an average $8.15 ($1,561,605)
  17. 4 Open-market buy Director bought 8,005 shares at an average $6.25 ($50,030)
  18. 4 Exercise or conversion Director acquired 600 shares (option exercise)
  19. 4 Exercise or conversion Director acquired 600 shares (option exercise)
  20. 4 Open-market buy Director bought 100,000 shares at an average $6.68 ($667,500)

Page 5 of 12 · 235 filings